Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

5.6%

2 terminated out of 36 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

28%

10 trials in Phase 3/4

Results Transparency

27%

6 of 22 completed with results

Key Signals

6 with results92% success

Data Visualizations

Phase Distribution

24Total
Not Applicable (10)
P 1 (1)
P 2 (3)
P 3 (7)
P 4 (3)

Trial Status

Completed22
Unknown8
Recruiting2
Terminated2
Withdrawn1
Not Yet Recruiting1

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 22 completed trials

Clinical Trials (36)

Showing 20 of 20 trials
NCT07316244Not Yet RecruitingPrimary

Pattern of Microbial Keratitis in Assiut University Hospital

NCT05432336Recruiting

Complex Ocular Infection, Optimization of Microbiological Diagnosis

NCT04420962CompletedPrimary

Automated Quantitative Ulcer Analysis Study

NCT06229379Not ApplicableCompleted

The Effects of a Large Language Model on Clinical Questioning Skills

NCT05250583Phase 2TerminatedPrimary

Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Treatment-Resistant Keratitis

NCT01272271CompletedPrimary

Safety of Overnight Corneal Reshaping Lenses

NCT01756456Phase 1Completed

Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis.

NCT03237936Phase 4CompletedPrimary

Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis

NCT05183906RecruitingPrimary

Evaluation of Next-Generation Sequencing-based Metabarcoding Versus Culturing for Microbiological Assessment in Infectious Keratitis

NCT05538793CompletedPrimary

Deep Learning for the Discrimination Among Different Types of Keratits: a Nationwide Study

NCT06070883Not ApplicableCompletedPrimary

Efficacy of Mutilayered Fresh Amnoitic Membrane Transplantation in Resistant Fungal Keratitis

NCT05689996Phase 3UnknownPrimary

Ozone-based Eye Drops as Adjuvant Therapy in Microbial Keratitis

NCT05255016Phase 2UnknownPrimary

Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers

NCT05255107Phase 2UnknownPrimary

Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers

NCT04169061Phase 4CompletedPrimary

Impact of Acthar on Everyday Life of Participants With Severe Keratitis

NCT01794312Phase 3CompletedPrimary

Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer

NCT03586505Not ApplicableCompletedPrimary

Tolerance to Light for Patients Suffering From Keratitis

NCT04075669Unknown

Multiplex Strip Polymerase Chain Reaction for Diagnosis of Eye Infection Diseases From Corneal Scraping Samples

NCT02116062Not ApplicableTerminatedPrimary

Robotic Surgery of the Ocular Surface

NCT03706443Not ApplicableCompleted

Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye Drops

Scroll to load more

Research Network

Activity Timeline